Adenocarcinoma News and Research

RSS
Adenocarcinoma is cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties.
Tumors use unique mechanism to switch on regulatory T cells for protection

Tumors use unique mechanism to switch on regulatory T cells for protection

Endocrine-targeted therapies can prevent and treat endometrial cancer recurrence

Endocrine-targeted therapies can prevent and treat endometrial cancer recurrence

COVID-19 may alter host proteins to cause autoimmunity

COVID-19 may alter host proteins to cause autoimmunity

Gastroesophageal reflux disease is linked with higher risks of larynx and esophageal cancers

Gastroesophageal reflux disease is linked with higher risks of larynx and esophageal cancers

Older patients often do not receive optimal therapy for esophageal cancers due to perceived risks

Older patients often do not receive optimal therapy for esophageal cancers due to perceived risks

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Study: MRI is reliable for intrapelvic T staging of neuroendocrine carcinoma

Study: MRI is reliable for intrapelvic T staging of neuroendocrine carcinoma

New study confirms the effectiveness of LDCT screening in a never-smoker high-risk population

New study confirms the effectiveness of LDCT screening in a never-smoker high-risk population

Researchers examine the connection between lung cancer and COVID-19

Researchers examine the connection between lung cancer and COVID-19

Researchers develop an easier way to deliver pancreatic cancer drugs

Researchers develop an easier way to deliver pancreatic cancer drugs

Researchers identify protein that may represent a safer treatment target for pancreatic cancer

Researchers identify protein that may represent a safer treatment target for pancreatic cancer

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

Dynamic, customized treatment approaches for gastroesophageal cancers may improve survival rates

SARS-CoV-2-induced innate immune responses may vary with disease severity, finds study

SARS-CoV-2-induced innate immune responses may vary with disease severity, finds study

No added risks to radiation therapy for cancer patients with COVID-19, says study

No added risks to radiation therapy for cancer patients with COVID-19, says study

Study shows rising incidence of esophageal adenocarcinoma in younger adults

Study shows rising incidence of esophageal adenocarcinoma in younger adults

Imaging, morphologic metrics associated with pathologic response in pancreatic cancer patients

Imaging, morphologic metrics associated with pathologic response in pancreatic cancer patients

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Are SARS-CoV-2 protease inhibitors effective antivirals in treating COVID-19?

Are SARS-CoV-2 protease inhibitors effective antivirals in treating COVID-19?

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

JNCCN: Cost-effectiveness of olaparib for metastatic pancreatic cancer

JNCCN: Cost-effectiveness of olaparib for metastatic pancreatic cancer